Long-term exposure to estrogens including those in traditional hormone replacement therapy (HRT) increases the risk of developing hormone-dependent cancers. As a result, women are turning to over-the-counter (OTC) botanical dietary supplements such as black cohosh (Cimicifuga racemosa) and hops (Humulus lupulus) as natural alternatives to HRT. The two major mechanisms which likely contribute to estrogen and/or HRT cancer risk are: the estrogen receptor (ER) mediated hormonal pathway; and, the chemical carcinogenesis pathway involving formation of estrogen quinones that damage DNA and proteins, hence initiating and promoting carcinogenesis. Since OTC botanical HRT alternatives are in widespread use they may have the potential for chemopreventive effects on estrogen carcinogenic pathways in vivo.
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epidermal growth factor (20 ng/mL), hydrocortisone (0.5 µg/mL), insulin (10 µg/L) and 5% CO 2 at 37 °C as described previously (15) . Estrogen-free medium for MCF-10A cells were prepared supplementing charcoal-dextran treated fetal bovine serum to phenol red free DMEM/F12, whereas other components remain the same. MCF-10A cells were authenticated using single tandem repeat analysis (STR).
Analysis of estrogen metabolites in MCF-10A cells
MCF-10A cells were seeded in 6 well plates at a density of 2000 cells/well. Cells were incubated with E 2 (1 µM) in the presence or absence of hops (5 µg/mL) and black cohosh (20 µg/mL) for 6 days. Since 20 µg/mL of hops showed toxicity in MCF-10A cells, lower concentrations of hops (5 µg/mL) was used for all the experiments. Since, hops showed a significant inhibition of estrogen metabolism at 5 µg/mL in MCF-10A cells, a dose response was performed. Different concentrations of hops (1, 2, 5, 7.5, 10 µg/mL) were tested in the presence of E 2 (1 µM). The effect of the hops compounds XH and 8-PN on estrogen metabolism were also studied. The dose dependent effect of XH (0.1, 0.5, 1, 2.5, 5 µM) and 8-PN (0.5, 1, 2.5, 5 µM) was tested in the presence of E 2 (1 µM).
Treatments were renewed every 3 days. Cell media was collected (5 mL/well) after 3 days of treatment and stored at -20 °C. At the end of the treatment, cell media was collected and pooled with the 3 rd day cell media (10 mL/sample total volume). Ascorbic acid (2 mM) and 5 nM 8
LC-MS/MS method
All of the metabolism experiments were performed using positive ion electrospray tandem mass spectrometric methodology on a API 3000 (Applied Biosystem min. The mass spectrometer parameters were optimized as follows: the ionspray voltage was 4.5 kV, the source temperature was 350 °C, the nebulizer gas was 12 instrument units, the curtain gas was 8 units, and the collision gas was 5 units. The focusing potential (FP) was 370 and the declustering potential (DP) was 81 V. The collision energy for 2-MeOE 1 , 4-MeOE 1 , and 
Cytotoxicity
Cytotoxicity assays were performed in parallel to all the metabolism experiments. 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay was performed to measure cell viability as described previously (32) .
Inhibition of human recombinant CYP450 1B1
Human recombinant CYP450 1B1 isozymes with CYP450 reductase were purchased from Sigma. Reaction mixture (1 mL) containing, recombinant CYP450 1B1 (10 pmol), E 2 (5 µM), potassium phosphate buffer (50 mM, pH = 7.4) and either hops (20 µg/mL) or 8-PN (1 µM) was pre-incubated at 37 °C for 5 min. The reaction was initiated by adding NADPH (1 mM) into each reaction mixture and incubated for 1 h at 37 °C. The reaction was quenched by addition of 100 µL of acetonitrile at 0 °C and protein was removed by centrifugation (10,000 rpm for 10 min). Ascorbic acid (2 mM) was added in to each sample before 4-OHE 1 -d 4 (5 nM) was added as the internal standard. Estrogen metabolites were extracted with dichloromethane (2 x 2 mL) and derivatized with dansyl chloride and analyzed by LC-MS/MS as described above for the metabolism experiments. Inhibition of CYP450 1B1 activity was further confirmed using the ethoxyresorufin O-dealkylase assay (supplementary Fig. S1B ) as described previously (33) with minor modifications. Briefly, recombinant CYP450 1B1 was incubated with E 2 (1 µM) and NADPH (1 mM) in potassium phosphate buffer (50 mM, pH = 7.4) in the presence and absence of different concentrations of hops (1-40 µg/mL). Activity of CYP450 1B1 was measured after incubating the reaction mixture at 37 °C for 10 min and determined as percentage CYP450 1B1 activity calculated from the resorufin standard curve.
Immunoblotting
Protein expression of CYP450 1B1 and 1A1 was analyzed using western blot experiments as previously described (34) Blots were visualized using chemiluminescence substrate (Thermo scientific, Rockford, IL).
Imaging and analysis was done using FluroChem software (Cell Biosciences, Santa Clara, CA).
Each protein band density was normalized to the respective β-actin band density and was represented as the relative protein expression. Three independent experiments were done to get the average and the results were represented as average ± SD.
Anchorage independent growth assay
To determine the effects of hops and it's flavonoids on estrogen-induced malignant transformation, anchorage independent growth assay was performed as previously described 
Results

Analysis of estrogen metabolism in MCF-10A cells
Oxidative estrogen metabolism was assessed by LC-MS/MS and MeOE 1 metabolites were measured in MCF-10A cell culture supernatants (Fig. 2, supplementary Fig. S2 ). Since COMT converts 2-hydroxyestrone and 4-hydroxyestrone into the corresponding 2-and 4-methoxy metabolites ( Fig. 1) , these served as indices of catechol estrogen formation (35) .
When the cells were treated with E 2 (1 µM) for 6 days and the cell media was analyzed for metabolites, the majority of the metabolites detected were estrone derivatives, while E 2 metabolites were much less abundant (supplementary Fig. S2 ). As a result, the methoxy estrone metabolites (MeOE 1 ) were used as biomarkers for metabolism, since they were stable in cell media compared to the catechol estrogens and could be consistently and reproducibly measured.
Hops inhibits estrogen metabolism in MCF-10A cells while black cohosh had no significant effect
To determine whether hops and black cohosh modulated estrogen metabolism, MCF-10A cells were treated with E 2 (1 µM) in the presence or absence of either hops (5 µg/mL) or black cohosh extracts (20 µg/mL) for 6 days. Since cell viability experiments indicated that 20 µg/mL of hops was toxic to MCF-10A cells (LC 50 = 11 ± 0.5 µg/mL), hops extract was used at lower concentrations (5 µg/mL) in the metabolism experiments. Black cohosh was not toxic and did not show any significant effect on estrogen metabolism in MCF-10A cells ( Fig. 2A) . In contrast, co-treatment with hops (5 µg/mL) significantly reduced (p < 0.005) the formation of both 2-and 4-estrone methylethers (Fig. 2B) . Hops extract reduced estrogen metabolism in a dose dependent manner in MCF-10A cells (Fig. 3) .
Hops modulates estrogen-induced CYP450 enzymes in MCF-10A cells
There are several important CYP450 enzymes involved in the estrogen chemical carcinogenesis pathway (Fig. 1) . In breast epithelial cells, the CYP 1 family is mainly involved in (5, 12) . Direct inhibition of CYP450 1B1 metabolism by hops extracts was analyzed and the data showed that toxic concentrations were necessary before any significant inhibition of estradiol metabolism or ethoxyresorufin O-dealkylation activity was observed (supplementary Fig. S1A, B) . In order to determine the effect of hops on E 2 induced P450 enzymes, MCF-10A cells were treated with E 2 (1 µM) in the presence or absence of hops (5 µg/mL) for 1, 3, and 6 days and protein expression was analyzed by immunoblotting (Fig. 4 ).
There was a significant time-dependent induction in CYP450 1B1 and CYP450 1A1 with E 2 treatment with maximum induction at day 6 (Fig. 4) . Co-treatment with hops (5 µg/mL) significantly inhibited the induction of both CYP450 1B1 (Fig. 4A ) and CYP450 1A1 (Fig. 4B ).
There was no significant effect on COMT by either E 2 or hops (Fig. 4C) .
Effect of XH and 8-PN on estrogen metabolism
XH exhibits chemopreventive activity (26) , whereas 8-PN shows estrogenic activity (21).
Since pure standards of these compounds were available, they were tested for their effect on estrogen metabolism. No significant reduction in the formation of 2-and 4-MeOE 1 was observed with co-treatment of different concentrations of XH in MCF-10A cells (Fig. 5) . In contrast, there was a significant reduction (p < 0.001) in the formation of 2-and 4-MeOE 1 in the presence of nanomolar amounts of 8-PN (Fig. 5) .
Anchorage independent growth inhibition by hops and active compounds.
The ability to form anchorage independent colonies in soft agar is considered an important hallmark of malignant transformation (14) . When MCF-10A cells were treated for 3 weeks and plated on soft agar for 3 weeks, there was a significant increase in anchorage independent colony formation in the E 2 treated sample (1 µM) compared to the negative control (0.01% DMSO) (Fig. 6) . Co-treatment with hops (5 µg/mL) significantly inhibited (p < 0.005), E 2 induced colony formation in soft agar. Finally, there was also a significant reduction (p < 0.0001) in colony formation with co-treatment with 8-PN (50 nM). 
Discussion
In addition to the widely accepted hormonal mechanism of estrogen carcinogenesis, estrogens can be metabolized by CYP450s to form redox active and/or electrophilic o-quinones, which could act as chemical carcinogens by modifying cellular macromolecules (5, 36) (Fig. 1 ).
An imbalance in estrogen metabolism results from increased CYP450-catalyzed o-quinone formation and/or reduced detoxification of these o-quinones, which could affect DNA integrity and lead to transformation of normal cells into a malignant phenotype (17) . In the present study, OTC botanical dietary supplements used as alternatives to estrogen replacement therapy, including black cohosh and hops, were analyzed for their ability to modulate oxidative estrogen metabolism in MCF-10A cells. We hypothesized that hops in particular could reduce oxidative estrogen metabolism, transformation of MCF-10A cells, and ultimately prevent estrogen dependent cancers.
Analysis of oxidative estrogen metabolites in biological samples has been reported using a variety of different methods including LC-MS/MS, GC-MS, and immunoassay (31, 37, 38) . A LC-MS/MS method was used in the present study in order to accurately measure and quantify 2-MeOE 1 and 4-MeOE 1 in MCF-10A cells (Fig. 2) . Since the stability of the catechol estrogens in the cell media was low, the quantity of the methoxy ethers was measured instead, assuming that their production was reflective of catechol estrogen formation (35) . Catechol estrogen formation has been measured in MCF-10F cells although pre-exposure to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) to induce CYP450s 1B1/1A1 was necessary as well as including the COMT inhibitor, Ro-41-0960 in the incubations (39) . In the present study, extraction of estrogen metabolites with dichloromethane increased extraction efficiency relative to solid phase extraction, while derivatization with dansyl chloride enhanced the ionization ability in the triple quadruple mass spectrometer leading to higher sensitivity. The LC-MS/MS method used in the present study was sufficiently sensitive to detect 2-and 4-MeOE 1 Black cohosh did not significantly inhibit estrogen metabolism in MCF-10A cells at 20 µg/mL concentration ( Fig. 2A) . In contrast, hops showed a significant dose-dependent inhibition towards the formation of 2-and 4-MeOE 1 (Fig. 2B, 3 ). Similar modulation of estrogen metabolism has been reported for resveratrol in MCF-10F cells and with dietary berries in animal models (44) .
Several potential mechanisms could explain the inhibitory effect of hops on estrogen metabolism. Components of hops could act as direct inhibitors of CYP450 1B1 and 1A1. For example, resveratrol was reported to be an inhibitor of CYP450 1B1 and 1A1, with nanomolar potency (33) . However, similar studies in CYP450 1B1 and 1A1 supersomes, in which E 2 was used as substrate, did not show inhibition below micromolar concentrations of resveratrol (16) .
Similarly, hops had no effect on CYP450 1B1 estrogen 4-hydroxylase or ethoxyresorufin Odealkylase activity unless toxic concentrations were used (> 20 µg/mL, supplementary Fig.S1 ).
Another possible inhibitory mechanism could involve inhibition of E 2 -induced CYP450 upregulation. It has been previously shown that E 2 induces the expression of CYP450 1B1 in MCF-7 cells through a mechanism involving both ERE and ERα (45) . Furthermore, CYP450
1A1 expression can also be induced by E 2 in HEPA 1C1C7 cells via transcriptional regulation (46) . In the present study, a time dependent induction in CYP450 1B1 and 1A1 expression in MCF-10A cells was observed upon exposure to E 2 (Fig. 4) . Since MCF-10A cells do not respond to estrogen via classical ERα genomic pathways, the mechanism of CYP450 induction by E 2 could involve extranuclear ER, ERβ, or aryl hydrocarbon receptor (AhR) since these receptors are expressed in MCF-10 cells (47) . In the present study, hops significantly inhibited estrogen-induced CYP450 1B1 and 1A1 expression in MCF-10A cells (Fig. 4) .
Since hops showed a significant inhibition in oxidative estrogen metabolism in MCF-10A cells, isolated phenolic components from hops were further studied. XH is the most abundant and bioactive phytoconstituent of hops (48), which has previously been reported to have potential chemopreventive properties via induction of NADPH-dependent quinone oxidoreductase (NQO1) in liver cells (26) . However, no significant inhibition of estrogen metabolism by XH was observed in MCF-10A cells (Fig. 5) . In contrast, 8-PN which is a potent estrogenic compound isolated from hops (21), showed a significant inhibitory effect (p < 0.0005) even at nanomolar concentrations (Fig. 5) . Although 8-PN showed a significant inhibition on estrogen metabolism in MCF-10A cells, it had little inhibitory effect on CYP450 1B1 catalyzed formation of 4-hydroxyestradiol in estradiol metabolism experiments using recombinant CYP450 1B1 enzyme (supplementary Fig. S1A ). It has been reported that 8-PN can act via ER-β to modulate gene expression in rat brain cells (49) . The mechanism of inhibition of oxidative estrogen metabolism in MCF-10A cells by 8-PN could be through inhibition of E 2 upregulation of CYP450 1B1, which could be mediated through ER-β, extranuclear ER, or AhR.
The ability to form anchorage independent colonies in semi-solid media is considered a characteristics of malignant transformation (14) . It has previously been shown that MCF-10A and 10F cells can undergo malignant transformation upon exposure to E 2 (15, 17) and E 2 induced malignant transformation could be inhibited by botanical components such as resveratrol (17, 42) . In the present study, it was confirmed that MCF-10A cells were transformed into a malignant phenotype upon exposure to E 2 (Fig. 6) . Anchorage independent colony formation in the E 2 treated cells was significantly higher (p < 0.001) than that of the 
negative control (0.01% DMSO) (Fig. 6 ). There was a significant inhibition (p < 0.005) of E 2 induced malignant transformation by hops (Fig. 6) . 8-PN which is a potent inhibitor of oxidative estrogen metabolism in MCF-10A cells (Fig. 5 ) also caused a significant reduction (p < 0.0001) in E 2 -induced malignant transformation when used in nanomolar (50 nM) amounts (Fig. 6 ).
These data suggest that 8-PN could be responsible for the effects of hops extract on E 2 [hops] μg/mL 
